← Leaderboards
Alan R Buckpitt
University Of California Davis
$10,908,360
Attributed
$14,906,631
Total exposure
20
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$14,906,631 · 20
By mechanism
UG3$6,082,654 · 1
R01$4,365,008 · 3
P42$1,681,673 · 2
R44$1,514,480 · 1
R43$492,639 · 2
UH2$274,162 · 1
Top collaborators
- Bruce D Hammock9 shared
Most similar at University Of California Davis
Same institution · by research overlap
- Charles G. Plopper$12,139,766
- Dallas M Hyde$27,257,239
- Jesse Joad$471,627
- Edward S Schelegle$3,639,449
- Reen Wu$17,190,535
Others in their field
Top investigators on “Naphthalenes”
- Laura S Van Winkle · University Of California Davis$5,268,090
- Brigid L.m. Hogan · Vanderbilt University$4,054,737
- Yogesh Chandra Awasthi · University Of Texas Medical Br Galveston$3,885,535
- John D Lipscomb · University Of Minnesota Twin Cities$3,752,407
- Xinxin Ding · University Of Arizona$3,614,619
- Eric N Olson · Ut Southwestern Medical Center$3,583,875
Research focus
NaphthalenesRodentToxic EffectMacaca MulattaEnzymesProgramsDoseLung InjuryMetabolismEpoxide HydrolaseBaseIn VivoCytotoxicityRattusAdductLaboratory MouseLaboratory RatMetabolic ActivationCytochrome P450United States National Institutes Of HealthExposure ToMonitorAnalgesicsPainful Neuropathy
Grant awards (45)
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$3,046,519
UG3 · FY2020 · DA · contact PI
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$3,036,135
UG3 · FY2019 · DA · contact PI
Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain$268,196
R43 · FY2019 · CA · contact PI
sEH Inhibitors to Treat Neuropathic Pain$705,128
R44 · FY2017 · ES · contact PI
Development of an Oral Analgesic for Neuropathic Pain$125,246
UH3 · FY2017 · NS · contact PI
sEH Inhibitors to Treat Neuropathic Pain$1,382
R44 · FY2017 · ES · contact PI
sEH Inhibitors to Treat Neuropathic Pain$731,876
R44 · FY2016 · ES · contact PI
Development of an Oral Analgesic for Neuropathic Pain$224,163
UH2 · FY2016 · NS · contact PI
sEH Inhibitors to Treat Neuropathic Pain$76,094
R44 · FY2016 · ES · contact PI
Development of an Oral Analgesic for Neuropathic Pain$49,999
UH2 · FY2016 · NS · contact PI
sEH Inhibitors to Treat Neuropathic Pain$224,443
R43 · FY2014 · ES · contact PI
Project 4: Urinary Protein Biomarkers for Assessing the Potential Toxicity$2,976
P42 · FY2014 · ES · contact PI
Project 4: Urinary Protein Biomarkers for Assessing the Potential Toxicity$149,987
P42 · FY2013 · ES · contact PI
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$25,210
P51 · FY2011 · RR · contact PI
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$37,989
P51 · FY2010 · RR · contact PI
Lung Injury by Naphthalenes$335,023
R01 · FY2009 · ES · contact PI
Biomarkers of Exposure to Pulmonary Toxicants$180,088
P42 · FY2009 · ES · contact PI
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$35,596
P51 · FY2009 · RR · contact PI
Lung Injury by Naphthalenes$335,023
R01 · FY2008 · ES · contact PI
Biomarkers of Exposure to Pulmonary Toxicants$190,220
P42 · FY2008 · ES · contact PI
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$27,111
P51 · FY2008 · RR · contact PI
Lung Injury by Naphthalenes$341,204
R01 · FY2007 · ES · contact PI
Biomarkers of Exposure to Pulmonary Toxicants$175,157
P42 · FY2007 · ES · contact PI
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$24,607
P51 · FY2007 · RR · contact PI
Lung Injury by Naphthalenes$341,063
R01 · FY2006 · ES · contact PI
Biomarkers of Exposure to Pulmonary Toxicants$163,544
P42 · FY2006 · ES · contact PI
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$24,804
P51 · FY2006 · RR · contact PI
Lung Injury by Naphthalenes$344,375
R01 · FY2005 · ES
Biomarkers of Exposure to Pulmonary Toxicants$158,781
P42 · FY2005 · ES
P450 MEDIATED LUNG TOXICITY$27,726
P51 · FY2005 · RR
METABOLIC ACTIVATION OF AIR TOXICS IN ASTHMATIC MONKEYS$27,726
P51 · FY2005 · RR
LUNG INJURY BY NAPHTHALENES$305,438
R01 · FY2004 · ES
LUNG INJURY BY NAPHTHALENES$297,602
R01 · FY2003 · ES
P450 MEDIATED LUNG TOXICITY$308,560
R01 · FY2002 · ES
LUNG INJURY BY NAPHTHALENES$289,994
R01 · FY2002 · ES
BIOMARKERS OF EXPOSURE TO PULMONARY TOXICANTS$165,230
P42 · FY2002 · ES
BIOMARKERS OF EXPOSURE TO PULMONARY TOXICANTS$165,230
P42 · FY2002 · ES
P450 MEDIATED LUNG TOXICITY$300,504
R01 · FY2001 · ES
LUNG INJURY BY NAPHTHALENES$282,106
R01 · FY2001 · ES
CDNA MICROARRAY TO DETECT CELLULAR RESPONSES TO MIXTURES$277,785
R01 · FY2001 · ES
BIOMARKERS OF EXPOSURE TO PULMONARY TOXICANTS$165,230
P42 · FY2001 · ES
ACQUISITION OF MIRCOARRAY SPOTTER, READER, SOFTWARE$140,000
S10 · FY2001 · RR
CDNA MICROARRAY TO DETECT CELLULAR RESPONSES TO MIXTURES$313,648
R01 · FY2000 · ES
P450 MEDIATED LUNG TOXICITY$292,683
R01 · FY2000 · ES
BIOMARKERS OF EXPOSURE TO PULMONARY TOXICANTS$165,230
P42 · FY2000 · ES